Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksKore Potash Regulatory News (KP2)

Share Price Information for Kore Potash (KP2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.50
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.05 (10.00%)
Open: 0.525
High: 0.525
Low: 0.525
Prev. Close: 0.525
KP2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CDI Monthly Movement

6 Jun 2023 07:00

RNS Number : 6605B
Kore Potash PLC
06 June 2023
 

6 June 2023

Kore Potash Plc

("Kore Potash" or the "Company")

CDI Monthly Movement

 

Kore Potash (ASX: KP2, AIM: KP2, JSE: KP2) advises the following movements in CDIs over its ordinary shares during May 2023:

 

Balance - 30 April 2023

665,337,133

Net Movement*

-

Balance - 31 May 2023

665,337,133

 

* Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required by the ASX to be reported on a minimum monthly basis.

 

A copy of the Appendix 4A lodged with the ASX is attached below.

 

 

ENDS

 

For further information, please visit www.korepotash.com or contact:

 

Kore Potash

Brad Sampson - CEO

 

Tel: +27 84 603 6238

Tavistock Communications

Emily Moss

Adam Baynes

 

Tel: +44 (0) 20 7920 3150

SP Angel Corporate Finance - Nomad and Joint Broker

Ewan Leggat

Charlie Bouverat

 

Tel: +44 (0) 20 7470 0470

Shore Capital - Joint Broker

Toby Gibbs

James Thomas

 

Tel: +44 (0) 20 7408 4050

Questco Corporate Advisory - JSE Sponsor

Doné Hattingh  

 

Tel: +27 (11) 011 9205

 

 

Appendix 4A

Statement of CDIs on issue

Information and documents given to ASX become ASX's property and may be made public.

*Denotes minimum information required for first lodgement of this form.

Part 1 - Entity and announcement details

Question no

Question

Answer

1.1

*Name of entity

We (the entity named above) provide the following information about our issued capital.[1]

KORE POTASH PLC

1.2

*Registration type and number

Please supply your ABN, ARSN, ARBN, ACN or another registration type and number (if you supply another registration type, please specify both the type of registration and the registration number).

ARBN 621843614

1.3

*ASX issuer code

KP2

1.4

\* The announcement is

Tick whichever is applicable.

ü New announcement

Update/amendment to previous announcement

Cancellation of previous announcement

1.4a

*Reason for update

Mandatory only if "Update" ticked in Q1.4 above. A reason must be provided for an update.

N/A

1.4b

*Date of previous announcement to this update

Mandatory only if "Update" ticked in Q1.4 above.

N/A

1.4c

*Reason for cancellation

Mandatory only if "Cancellation" ticked in Q1.4 above.

N/A

1.4d

*Date of previous announcement to this cancellation

Mandatory only if "Cancellation" ticked in Q1.4 above.

N/A

1.5

*Date of this announcement

Tuesday, 6 June 2023

Part 2 - Details of CDIs and other securities on issue

Question No.

Question

Answer

2.1

*Statement for month and year

Appendix 4A should be provided within 5 business days of the calendar month end, regardless of whether there is a change or not.

Month: May

Year: 2023

2.2

*Number and class of all ASX-quoted CDIs on issue:

Repeat the following information for each class of CDIs quoted on ASX

ASX security code:

KP2

Security description:

CHESS DEPOSITARY INTERESTS 1:1

CDI ratio[2]:

1:1

Total number of CDIs quoted on ASX at end of statement month (A):

665,337,133

Total number of CDIs quoted on ASX at end of previous month (B):

665,337,133

Net difference[3] (A-B):

 

-

Reason for change:

Net transfers of securities between CDIs and ordinary shares as quoted / held on AIM and JSE.

 

If the total number of CDIs quoted on ASX at the end of the statement month (A), is greater than the total number of CDIs for which the entity has previously paid an initial listing fee or an additional listing fee under Table 1A and 1C of Guidance Note 15A (C), the entity hereby applies for +quotation of the difference (A - C) and agrees to the matters set out in Appendix 2A of the ASX Listing Rules.

 

2.3

*Number and class of all issued securities not represented by CDIs quoted on ASX:

Repeat the following table for each class of issued securities not represented (in whole or in part) by CDIs quoted on ASX

ASX security code:

KP2AA

Security description:

ORDINARY FULLY PAID

Total number of securities at end of statement month (A):

2,756,599,987

Total number of securities at end of previous month (B):

2,756,999,987

Net difference (A-B):

 

-

Reason for change:

Net transfers of securities between CDIs and ordinary shares as quoted / held on AIM and JSE.

 

 

 

ASX security code:

KP2AB

Security description:

OPTION EXPIRING 19-JUL-2024 EX GBP 0.022

Total number of securities at end of statement month (A):

26,900,000

Total number of securities at end of previous month (B):

26,900,000

Net difference (A-B):

 

0

Reason for change:

Not applicable.

 

ASX security code:

KP2AF

Security description:

OPTION EXPIRING 01-JAN-2024 EX 2.2

Total number of securities at end of statement month (A):

20,000,000

Total number of securities at end of previous month (B):

20,000,000

Net difference (A-B):

 

0

Reason for change:

Not applicable.

 

 

Introduced 01/12/19

 


[1] Listing rule 4.11 requires an entity that has a dual listing on ASX and an overseas exchange and has CDIs issued over quoted securities, to complete an Appendix 4A and give it to ASX within 5 business days of the end of each month. An entity that has a dual listing on ASX and an overseas exchange and that is proposing to issue new equity securities and to have quoted CDIs over some or all of them, should notify ASX of the proposed issue of the underlying securities using an Appendix 3B and apply for the CDIs to be quoted using an Appendix 2A.

 

[2] This is the ratio at which CDIs can be transmuted into the underlying security (e.g. 4:1 means 4 CDIs represent 1 underlying security whereas 1:4 means 1 CDI represents 4 underlying securities).

[3] The net difference should equal the number of underlying securities transmuted into CDIs during the month less the number of CDIs transmuted into underlying securities during the month

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKELBBXQLXBBK
Date   Source Headline
8th Jan 20197:00 amRNSCDI Monthly Movement
7th Dec 20188:50 amRNSMining Convention passed into Law
5th Dec 20187:00 amRNSCDI Monthly Movement
21st Nov 20187:00 amRNSExtensions to Sylvinite Deposits Expected
16th Nov 201811:06 amRNSSecond Price Monitoring Extn
16th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSCDI Monthly Movement
1st Nov 20187:00 amRNSDefinitive Feasibility Study ("DFS") Received
30th Oct 20189:01 amRNSCashflow Report for Q3 2018
30th Oct 20189:00 amRNSReview of Operations for Q3 2018
5th Oct 20189:00 amRNSCDI Monthly Movement
1st Oct 20187:00 amRNSCompany Secretary Change
28th Sep 20187:15 amRNSDefinitive Feasibility Study Update
12th Sep 201810:15 amRNSFINANCIAL REPORT FOR HALF YEAR ENDED 30 JUNE 2018
12th Sep 20187:00 amRNSDedicated Offshore Transhipment Area Licenced
10th Sep 20189:00 amRNSCDI Monthly Movement
28th Aug 20188:30 amRNSApproval of ESIA for Dougou licence area
20th Aug 201810:00 amRNSMaiden Sylvinite MRE at Dougou Extension
7th Aug 20183:23 pmRNSDirector/PDMR Shareholding - Replacement
7th Aug 20189:32 amRNSCDI Monthly Movement
7th Aug 20189:31 amRNSDirector / PDMR Shareholdings
7th Aug 20189:30 amRNSDirector / PDMR Shareholding
2nd Aug 20187:02 amRNSDirector Interest Notice
2nd Aug 20187:01 amRNSAppendix 3B
2nd Aug 20187:00 amRNSDirector Interest Notices
31st Jul 20187:01 amRNSReview of Operations for Q2 2018
31st Jul 20187:00 amRNSCashflow Report for Q2 2018
18th Jul 20189:30 amRNSCDI Monthly Movement
27th Jun 201811:01 amRNSResults of AGM
27th Jun 201811:00 amRNSExpiry of unlisted options
12th Jun 20188:45 amRNSCDI Monthly Movement
1st Jun 20188:00 amRNSAnnual Financial Report
30th May 20187:00 amRNSAppointment of CEO
23rd May 20187:00 amRNSAppointment of a Non-Executive Director
4th May 20188:00 amRNSCDI Monthly Movement
30th Apr 20189:31 amRNSReview of Operations for Q1 2018
30th Apr 20189:30 amRNSCashflow Report for Q1 2018
26th Apr 20183:40 pmRNSAdmission Document Disclosures
26th Apr 20183:37 pmRNSHolding(s) in Company
26th Apr 20181:30 pmRNSDirector Resignation
18th Apr 201810:00 amRNSExpiry of Unlisted Options
17th Apr 20189:30 amRNSDirector/PDMR Shareholding
13th Apr 20189:00 amRNSDirector/PDMR Shareholding
10th Apr 20188:00 amRNSASX waiver in relation to quotation of CDIs
9th Apr 201810:20 amRNSDirector/PDMR Shareholding
5th Apr 20181:09 pmRNSDirector/PDMR Shareholding
4th Apr 20181:55 pmRNSNotice under Section 708A
4th Apr 20181:49 pmRNSAppendix 3B
3rd Apr 20187:00 amRNSAnnual Financial Report
29th Mar 20187:00 amRNSAdmission to AIM and JSE and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.